SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cambridge Antibody Technology Group
An SI Board Since December 1999
Posts SubjectMarks Bans
625 23 0
Emcee:  Jongmans Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
350Found the clause in the original listing particulars. That will teach me to dig nigel bates-3/26/2003
349Me neither. It sounds like the agreement allowed ABT to enter into licensing agkeokalani'nui-3/26/2003
348I'm not happy on this. I feel that CAT been less than frank with shareholdernigel bates-3/26/2003
347<i>Looks as though the CAT bid for OGS is dead, judging by the initial marnigel bates-3/26/2003
346At the SGC conf, ABT said it's estimate of $1b peak Humira sales is for RA okeokalani'nui-3/21/2003
345Cambridge Antibody Technology Acknowledges Anthrax Drug Wednesday March 19, 6:42nigel bates-3/19/2003
344Schedule 1.15 Certain Library License Provisions 1.1.10nigel bates-3/15/2003
343Intriguing asterisks... Who is the * in this clause (and how much might the othnigel bates-3/15/2003
342So, no royalty due on Humira, but a royalty will be due on (eg) CAT-152. Some dnigel bates-3/15/2003
341<i>XOMA 10K, CAT licence agreement...</i> sec.gov PAYMENTS nigel bates-3/15/2003
34011 March 2003 Cambridge Antibody Technology Group plc Recommended Merger with Oxnigel bates-3/11/2003
339Abbott's Arthritis Drug Humira Is on Track to Hit Targets Monday March 10, 2keokalani'nui-3/10/2003
3382) Name of shareholder having a major interest FMR Corp, Fidelity International nigel bates-3/10/2003
337ABBOTT PARK, Ill., March 3 /PRNewswire-FirstCall/ -- Abbott Laboratories (NYSE: nigel bates-3/3/2003
336CAMBRIDGE, England, Feb. 13 /PRNewswire-FirstCall/ -- Cambridge Antibody Technolnigel bates-2/13/2003
335Ran across a comment that in first four weeks, the big H registered 8.2% of new keokalani'nui-2/11/2003
334Apologies if this data has already been posted: >>ABBOTT PARK, Ill., Jan.tuck-1/30/2003
333CAT pounces on Oxford biotech rival LONDON, Jan 23 (Reuters) - Britain's Canigel bates-1/23/2003
332Despite Humira, Abbott must still see mice as an option - Message 18465607 Meannigel bates-1/20/2003
331Just parking. (Interesting that Kawasaki's next patent was at ZymoGenetics.)nigel bates-1/18/2003
330Noticed in their latest job ads that they're still recruiting for their ribonigel bates-1/16/2003
329Humira Approval, Litigation End Spell Fresh Start To CAT's Year By Nuala Mkeokalani'nui-1/13/2003
328<i>I hope he was not looking at the sunk costs.</i> He's a renigel bates-1/8/2003
327maybe he was looking at the remaining marginal cost/benefit....doesn't mean keokalani'nui-1/8/2003
326They must have some confidence in the glaucoma thing to be throwing so much cashnigel bates-1/8/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News